NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Novasign GmbH

Novasign GmbH

Private
ViennaHealthcare & Life Scienceshttps://novasign.at/

Last Round

Seed

Sep 4, 2025

Total Funding Raised

$1.34M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Novasign GmbH is a biotechnology company that provides hybrid modeling software and consulting services to accelerate bioprocess development for the biopharmaceutical, enzyme, and cultured food industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical AI, Smart Manufacturing, ML Platforms, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

hybrid modelingdigital twinbioprocess developmentbioprocessing softwarein-silico simulationbioprocess optimizationprocess modelingDesign of ExperimentsDoE softwareupstream processingdownstream processingprocess scale-upbiopharmaceuticalMSATManufacturing, Science, and Technologycultured foodenzyme productionProcess Analytical TechnologyPAT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novasign GmbH Comparables

Compare Novasign GmbH with similar companies based on industry and business-model similarity.

Novasign GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DataHow AG
90%
AnalysisMode
85%
Algocell
84%

Novasign GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedSep 4, 2025

Key People

Founding team and executive leadership

Mark Duerkop

Co-Founder and CEO

Founding Team

Novasign GmbH Investors

Notable investors and investment history

Novasign GmbH investors
InvestorRounds
Austria WirtschaftsserviceGrant
FFG Austrian Research Promotion AgencyGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 29, 2026

    Grew 20% QoQ, from 20 to 24 employees.

  • Feb 17, 2026

    Grew 27% QoQ, from 15 to 19 employees.

Novasign GmbH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Novasign GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Novasign GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersVienna
Employee Range24
Year Founded2019
Last FundingSep 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.